The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates
MetadataShow full item record
Altmetrics Handle Statistics
Altmetrics DOI Statistics
Background : Up to 80 % of cases of prostate cancer present with multifocal independent tumour lesions leading to the concept of a field effect present in the normal prostate predisposing to cancer development. In the present study we applied Whole Genome DNA Sequencing (WGS) to a group of morphologically normal tissue (n = 51), including benign prostatic hyperplasia (BPH) and non-BPH samples, from men with and men without prostate cancer. We assess whether the observed genetic changes in morphologically normal tissue are linked to the development of cancer in the prostate. Results : Single nucleotide variants (P = 7.0x10-03, Wilcoxon rank sum test) and small insertions and deletions (indels, P = 8.7x10-06) were significantly higher in morphologically normal samples, including BPH, from men with prostate cancer compared to those without. The presence of subclonal expansions under selective pressure, supported by a high level of mutations, were significantly associated with samples from men with prostate cancer (P = 0.035, Fisher exact test). The clonal cell fraction of normal clones was always higher than the proportion of the prostate estimated as epithelial (P = 5.94x10-05, paired Wilcoxon signed rank test) which, along with analysis of primary fibroblasts prepared from BPH specimens, suggests a stromal origin. Constructed phylogenies revealed lineages associated with benign tissue that were completely distinct from adjacent tumour clones, but had a common lineage between BPH and non-BPH morphologically normal tissues was often observed. Compared to tumours, normal samples have significantly less single nucleotide variants (P = 3.72x10-09, paired Wilcoxon signed rank test), have very few rearrangements and a complete lack of copy number alterations. Conclusions : Cells within regions of morphologically normal tissue (both BPH and non-BPH) can expand under selective pressure by mechanisms that are distinct from those occurring in adjacent cancer, but that are allied to the presence of cancer. Expansions, which are probably stromal in origin, are characterised by lack of recurrent driver mutations, by almost complete absence of structural variants/copy number alterations, and mutational processes similar to malignant tissue. Our findings have implications for treatment (focal therapy) and early detection approaches.
Buhigas , C , Warren , A Y , Leung , W-K , Whitaker , H C , Luxton , H J , Hawkins , S , Kay , J , Butler , A , Xu , Y , Woodcock , D , Merson , S , Frame , F M , Sahli , A , Abascal , F , CRUK-ICGC Prostate Group , Martincorena , I , Bova , G S , Foster , C S , Campbell , P , Maitland , N , Neal , D E , Massie , C E , Lynch , A , Eeles , R A , Cooper , C S , Wedge , D C & Brewer , D S 2022 , ' The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates ' , Molecular Cancer , vol. 21 , 183 . https://doi.org/10.1186/s12943-022-01644-3
Copyright © The Author(s) 2022.Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence. The Creative Commons Public Domain Dedication waiver applies to the data made available in this article, unless otherwise stated in a credit line to the data.
DescriptionFunding: This project was funded by Cancer Research UK (C5047/A29626/A22530/A17528), the Dallaglio Foundation, and Prostate Cancer UK (TLD-S15-003).
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.